Literature DB >> 12900431

Hyperuricemia in childhood primary hypertension.

Daniel I Feig1, Richard J Johnson.   

Abstract

Experimental animal models suggest that uric acid might have a pathogenic role in the early development of primary hypertension. We hypothesized that serum uric acid is correlated with blood pressure in children with new-onset, untreated, primary hypertension. We evaluated 125 consecutive children referred to the Baylor Pediatric Renal Program for evaluation of hypertension. None of the subjects had previously been evaluated or treated for hypertension. The children ranged in age from 6 to 18 years (mean, 13.4+/-3.3) and had normal renal function (creatinine clearance >80 mL x min(-1) x 1.73 m(-2)). Sixty-three children had primary hypertension, 40 had secondary hypertension, and 22 had white-coat hypertension. Forty controls with normal blood pressure were recruited from the renal clinic. Uric acid levels were directly correlated with systolic (r=0.80, P=0.0002) and diastolic (r=0.66, P=0.0006) blood pressure in controls and in subjects with primary hypertension and were independent of renal function. Serum uric acid concentrations >5.5 mg/dL were found in 89% of subjects with primary hypertension, in 30% with secondary hypertension, in 0% with white-coat hypertension, and in 0% of controls. We conclude that serum uric acid is directly correlated with blood pressure in untreated children and that a serum uric acid value >5.5 mg/dL in an adolescent being evaluated for hypertension strongly suggests primary hypertension as opposed to white-coat or secondary hypertension. These results are consistent with the hypothesis that uric acid might have a role in the early pathogenesis of primary hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900431      PMCID: PMC1800942          DOI: 10.1161/01.HYP.0000085858.66548.59

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  41 in total

1.  Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

Authors:  M Mazzali; J Hughes; Y G Kim; J A Jefferson; D H Kang; K L Gordon; H Y Lan; S Kivlighn; R J Johnson
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

2.  White coat hypertension in adolescents.

Authors:  V H Koch; E A Furusawa; M I Saito; A Colli; E C Ignes; Y Okay; D Mion Júnior
Journal:  Clin Nephrol       Date:  1999-11       Impact factor: 0.975

3.  Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition.

Authors:  Y Quiroz; H Pons; K L Gordon; J Rincón; M Chávez; G Parra; J Herrera-Acosta; D Gómez-Garre; R Largo; J Egido; R J Johnson; B Rodríguez-Iturbe
Journal:  Am J Physiol Renal Physiol       Date:  2001-07

4.  Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).

Authors:  L V Franse; M Pahor; M Di Bari; R I Shorr; J Y Wan; G W Somes; W B Applegate
Journal:  J Hypertens       Date:  2000-08       Impact factor: 4.844

5.  Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

Authors:  J Fang; M H Alderman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

Review 6.  Ambulatory blood pressure monitoring in children and adolescents. Current insights into a new technique.

Authors:  M Bald
Journal:  Minerva Pediatr       Date:  2002-02       Impact factor: 1.312

7.  Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure.

Authors:  Martha Franco; Edilia Tapia; José Santamaría; Ignacio Zafra; Romeo García-Torres; Katherine L Gordon; Héctor Pons; Bernardo Rodríguez-Iturbe; Richard J Johnson; Jaime Herrera-Acosta
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

8.  Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension.

Authors:  J M Sorof; T Poffenbarger; K Franco; R Portman
Journal:  Am J Hypertens       Date:  2001-09       Impact factor: 2.689

9.  Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

Authors:  J Coresh; G L Wei; G McQuillan; F L Brancati; A S Levey; C Jones; M J Klag
Journal:  Arch Intern Med       Date:  2001-05-14

10.  Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension.

Authors:  J G Wang; J A Staessen; R H Fagard; W H Birkenhäger; L Gong; L Liu
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

View more
  139 in total

1.  Serum uric acid and cardiovascular disease.

Authors:  Adriana Iliesiu; Alexandru Campeanu; Dinu Dusceac
Journal:  Maedica (Buchar)       Date:  2010-07

2.  Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study.

Authors:  V Saroja Voruganti; Sandra Laston; Karin Haack; Nitesh R Mehta; Shelley A Cole; Nancy F Butte; Anthony G Comuzzie
Journal:  Am J Clin Nutr       Date:  2015-01-28       Impact factor: 7.045

3.  Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006.

Authors:  Mark D DeBoer; Lili Dong; Matthew J Gurka
Journal:  Metabolism       Date:  2011-10-13       Impact factor: 8.694

Review 4.  Recent advances in the epidemiology of gout.

Authors:  Kenneth G Saag; Ted R Mikuls
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

5.  Study of epidemiological aspects of hyperuricemia in Poland.

Authors:  Katarzyna Kostka-Jeziorny; Krystyna Widecka; Andrzej Tykarski
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

6.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

Review 7.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

8.  Determinants of inappropriate circadian blood pressure variability in children with essential hypertension.

Authors:  Lukasz J Krzych; Leslaw Szydlowski
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

Review 9.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

10.  The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan.

Authors:  Jianmin Yang; Zhendong Liu; Cheng Zhang; Yingxin Zhao; Shangwen Sun; Shujian Wang; Yuxia Zhao; Yun Zhang; Jifu Li; Fanghong Lu
Journal:  Rheumatol Int       Date:  2012-12-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.